SLC5A2 and neoplasm: It is noteworthy that the similar uptake in tumor tissues and reduced uptake in nontarget tissues also suggeste that SGLT2 inhibitors may be have beneficial for patient by reducing the radiation load to organs, and decreasing the harmful radiation toxicity.